NEW YORK--(BUSINESS WIRE)--The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of EndoChoice Holdings, Inc. (“EndoChoice”) (NYSE: GI) pursuant and/or traceable to the Company’s Registration Statement issued in connection with the Company’s Initial Public Offering on or about June 5, 2015.
You are hereby notified that a securities action has been commenced in the Superior Court of the State of Georgia. If you purchased or otherwise acquired EndoChoice Holdings securities pursuant to the Offering, your rights may be affected by this action. To get more information go to: http://www.zlk.com/pslra/endochoice-holdings-inc.
The complaint alleges that documents issued pursuant to the IPO were materially misleading and/or omitted material facts. On June 5, 2015, EndoChoice commenced an initial public offering of 6,350,000 shares of EndoChoice common stock at a price of $15.00 per share. Then on November 5, 2015, EndoChoice announced a decline in Fuse placements in the third quarter; the Company also announced it had entered into a strategic partnership with De Lage Landen Financial Services, Inc. to provide a new financing program for EndoChoice customers in the United States. Following this news, shares of EndoChoice fell more than 22 percent.
If you suffered a loss in EndoChoice and would like to obtain additional information, contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://www.zlk.com/pslra/endochoice-holdings-inc.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
